TOMI Q2 revenue jumps 124% to $2.3 million, margin expands
TOMI Environmental Solutions reported preliminary second-quarter 2026 revenue of $2.3 million, a 124% increase year-over-year. Combined with open orders of $6.2 million, the company has surpassed its full-year 2025 revenue. Gross margin expanded to 70% from 66% in the prior-year quarter.

*this image is generated using AI for illustrative purposes only.
TOMI Environmental Solutions, Inc. reported preliminary second-quarter 2026 revenue of approximately $2.3 million, representing a 124% increase year-over-year. The company’s performance was driven by accelerating momentum in its high-margin razor-and-blade business model, supported by a growing installed base of SteraMist iHP systems and recurring revenue from BIT Solution and related consumables. Combined with open orders of $6.2 million, TOMI has already surpassed its full-year 2025 revenue, demonstrating the scalability of its strategic initiatives across equipment, services, and consumables.
Financial Highlights
Gross margin expanded to 70% from 66% in the prior-year quarter. Key operational metrics for the second quarter include significant growth across mobile capital equipment, accessories, and support services. The company also noted that U.S. service provider rental activity increased 60% compared with all of 2025, driven by rising demand for flexible, on-demand iHP deployment.
| Segment | 2Q26 Revenue | Prior-Year Quarter Revenue | Change |
|---|---|---|---|
| Mobile Capital Equipment | $777,000 | $271,000 | 186% |
| Accessories | $200,000 | $104,000 | 91% |
| Support Services | $195,000 | $116,000 | 67% |
| Applicator Sales | $355,000 | $13,000 | N/A |
| BIT Solution | $304,000 | $224,000 | 35% |
Strategic Developments
TOMI has begun formally tracking a dedicated enclosure category as it scales delivery of iHP decontamination chambers for medical device manufacturing and life sciences facilities. The newly launched NV+ system was sold in a customized configuration to a major healthcare facility in Minnesota, with delivery scheduled for the third quarter. This order is expected to generate recurring revenue through BIT Solution and service contracts.
The company expanded its global reach by adding three new distributors covering the United States, South Africa, and Argentina, along with additional South American territories. Additionally, a prominent American healthcare company expanded a custom engineering contract into a significantly larger automation project late in the quarter. SteraMist was named the Disinfection and Decontamination Products Company of the Year for 2026 by Medical Tech Outlook.
Can the 124% revenue growth rate be sustained as the installed base matures?
How will the expansion into South Africa and Argentina impact logistics and operational costs?
What is the expected revenue contribution from the new dedicated enclosure category over the next year?
























